Body mass index (BMI), platelet count, and aspartate (AST) or alanine (ALT) aminotransferase levels are all important predictors of plasma leakage among dengue patients, a recent Thailand study has found.
A plasma-leak score consisting of these three variables can help clinicians easily assess the risk of their patients and provide timely intervention.
Researchers conducted a prospective observational analysis of 667 confirmed dengue patients (median age 26 years, 52.2 percent men), of whom 318 developed plasma leakage while 349 did not. The latter group had a significantly lower proportion of men (p=0.01) and BMI (p=0.009).
Multivariate logistic regression analysis revealed that BMI ≥25.0 kg/m2 was a significant and independent predictor of plasma leakage (odds ratio [OR], 1.795, 95 percent confidence interval [CI], 1.040–3.057; p=0.035).
Similarly, platelet count <100,000/mm3 (OR, 2.151, 95 percent CI, 1.269–3.647; p=0.004) and AST or ALT ≥100 U/L (OR, 2.189, 95 percent CI, 1.231–3.891; p=0.008) on days 3–4 of fever onset also emerged as significant correlates of plasma leakage.
Since the above three parameters showed evidence of equality, they were each assigned a weighted score of 1 point, yielding a plasma-leak score of 3 points.
Logistic regression showed that earning a score of 1, 2, or 3 points corresponded to plasma leakage ORs of 2.017 (95 percent CI, 1.052–3.869; p=0.035), 6.158 (95 percent CI, 2.914–13.015; p<0.001), and 6.300 (95 percent CI, 2.419–16.407; p<0.001), respectively. The plasma-leak score had an area under the receiver operating characteristic curve of 0.677.